series-c-plus
Stage
2
Investors
About
OptiNose is a specialty pharmaceutical company developing products using proprietary Bi-Directional Exhalation Delivery Systems to deliver drugs effectively for ear, nose, and throat and allergy conditions.
Explore OptiNose's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.